💊

Prescription Drugs

💊 Drugs 12,141 recalls

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Oct 29, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Oct 29, 2018 Prescription Drugs Nationwide View Details →

Presence of foreign substance: Product found to contain metal particles.

Nov 6, 2018 Prescription Drugs Nationwide View Details →

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Oct 29, 2018 Prescription Drugs Nationwide View Details →

Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that "These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation."

Nov 9, 2018 Prescription Drugs Nationwide View Details →

Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.

Oct 19, 2018 Prescription Drugs Nationwide View Details →